Association of HLA Class I and Class II genes with bcr-abl transcripts in leukemia patients with t(9;22) (q34;q11).

作者: Shailendra Mundhada , Rajyalakshmi Luthra , Pedro Cano

DOI: 10.1186/1471-2407-4-25

关键词:

摘要: Based on the site of breakpoint in t(9;22) (q34;q11), bcr-abl fusion leukemia patients is associated with different types transcript proteins. In this study we have seen association HLA genes transcripts. The could predict peptide presentation by particular molecules. included a total 189 mixed ethnicity chronic myelogenous and acute lymphocytic who were being considered for bone marrow transplantation. Typing transcripts was done reverse transcriptase PCR method. typing performed molecular methods. studied calculating relative risks chi-square test. Significant negative associations (p < 0.05) observed HLA-A*02 (b2a2, e1a2), -A*68 b3a2, -B*14 -B*15 b3a2), -B*40 (b2a2), -DQB1*0303 -DQB1*0603 -DRB1*0401 (e1a2), -DRB1*0701 (b3a2), -DRB1*1101 (b2a2). specific alleles suggests that these play critical role presenting peptides derived from chimeric proteins eliciting successful T-cell cytotoxic response. Knowledge differential between phenotypes would help developing better strategies immunization against (q34;q11)-positive leukemia.

参考文章(48)
D. Accapezzato, V. Barnaba, G. Alimena, R. Tosi, N. Tanigaki, R. Butler, D. Fruci, R. Nisini, G. Greco, E. Vigneti, E. Montefusco, Two bcr-abl junction peptides bind HLA-A3 molecules and allow specific induction of human cytotoxic T lymphocytes Leukemia. ,vol. 10, pp. 693- 699 ,(1996)
HM Kantarjian, A Deisseroth, R Kurzrock, Z Estrov, M Talpaz, Chronic myelogenous leukemia: a concise update Blood. ,vol. 82, pp. 691- 703 ,(1993) , 10.1182/BLOOD.V82.3.691.691
D. Niederwieser, J.H.F. Falkenburg, J.H. v Biezen, M. Oudshoorn, R. Willemze, J.F. Apperley, A. Gratwohl, E.F.M. Posthuma, B. Hertenstein, G.M.T. Schreuder, R.F. Schipper, J. D’Amaro, E. Roosnek, J. Hermans, HLA-B8 and HLA-A3 Coexpressed With HLA-B8 Are Associated With a Reduced Risk of the Development of Chronic Myeloid Leukemia Blood. ,vol. 93, pp. 3863- 3865 ,(1999) , 10.1182/BLOOD.V93.11.3863
M Bocchia, T Korontsvit, Q Xu, S Mackinnon, SY Yang, A Sette, DA Scheinberg, Specific human cellular immunity to bcr-abl oncogene-derived peptides Blood. ,vol. 87, pp. 3587- 3592 ,(1996) , 10.1182/BLOOD.V87.9.3587.BLOODJOURNAL8793587
P. C. Nowell, A minute chromosome in human chronic granulocytic leukemia Science. ,vol. 132, pp. 1497- ,(1960)
Pedro Cano, Bo Fan, A geometric and algebraic view of MHC-peptide complexes and their binding properties BMC Structural Biology. ,vol. 1, pp. 2- 2 ,(2001) , 10.1186/1472-6807-1-2
F Pane, F Frigeri, M Sindona, L Luciano, F Ferrara, R Cimino, G Meloni, G Saglio, F Salvatore, B Rotoli, Neutrophilic-chronic myeloid leukemia: a distinct disease with a specific molecular marker (BCR/ABL with C3/A2 junction) Blood. ,vol. 88, pp. 2410- 2414 ,(1996) , 10.1182/BLOOD.V88.7.2410.BLOODJOURNAL8872410